Oxford Square Capital Corp. is a business development company, which engages in the provision of capital to established businesses, investing in syndicated bank loans and purchasing debt and equity tranches of collateralized loan obligations. The company was founded on July 21, 2003 and is headquartered in Greenwich, CT.
Industry, Sector and Symbol
Industry Investment offices, not elsewhere classified
Sub-IndustryN/A
SectorFinance
Phone203-983-5275
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$61.42 million
Profitability
Miscellaneous
EmployeesN/A
OptionableOptionable
Oxford Square Capital (NASDAQ:OXSQ) Frequently Asked Questions
What is Oxford Square Capital's stock symbol?
Oxford Square Capital trades on the NASDAQ under the ticker symbol "OXSQ."
How often does Oxford Square Capital pay dividends? What is the dividend yield for Oxford Square Capital?
Oxford Square Capital declared a quarterly dividend on Friday, October 26th. Stockholders of record on Monday, December 17th will be given a dividend of $0.20 per share on Monday, December 31st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 11.94%. The ex-dividend date of this dividend is Friday, December 14th. View Oxford Square Capital's Dividend History.
How were Oxford Square Capital's earnings last quarter?
Oxford Square Capital Corp (NASDAQ:OXSQ) released its earnings results on Tuesday, October, 30th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.17 by $0.01. The business had revenue of $15.15 million for the quarter, compared to analyst estimates of $14.44 million. Oxford Square Capital had a net margin of 75.91% and a return on equity of 8.99%. View Oxford Square Capital's Earnings History.
When is Oxford Square Capital's next earnings date?
What price target have analysts set for OXSQ?
2 equities research analysts have issued 12 month price targets for Oxford Square Capital's shares. Their forecasts range from $5.00 to $5.00. On average, they anticipate Oxford Square Capital's share price to reach $5.00 in the next year. This suggests that the stock has a possible downside of 25.4%. View Analyst Price Targets for Oxford Square Capital.
What is the consensus analysts' recommendation for Oxford Square Capital?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Oxford Square Capital in the last year. There are currently 2 sell ratings for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Oxford Square Capital.
What are Wall Street analysts saying about Oxford Square Capital stock?
Here are some recent quotes from research analysts about Oxford Square Capital stock:
- 1. According to Zacks Investment Research, "Oxford Square Capital Corp. is a business development company principally investing in syndicated bank loans and debt and equity tranches of CLO vehicles. Oxford Square Capital Corp., formerly known as TICC Capital Corp., is based in Greenwich, United States. " (11/15/2018)
- 2. National Securities analysts commented, " For 3Q18, OXSQ posted estimated core NII/share of $0.20 versus our estimate of $0.19. Core numbers were not provided during the quarter in both the 8-K as well as the presentation and we are not sure why. However, we added back the $1.2 million in CLO equity reductions to cost in order to approximate estimated additional taxable income (EATI) and arrive at our core figures. This is unusual as OXSQ has reported this number consistently and dividend payout requirements for ’40 Act companies is based upon taxable income, not GAAP earnings or NII.
We expect credit spreads to widen due to technical factors (meaning we do not expect defaults to pick-up) from 1Q19-3Q19. As a result, core NII will likely increase significantly due to the favorable reinvestment environment afforded to CLOs but this will also cause severely negative marks on the portfolio which would cause NAV to decline. BDCs with CLO equity typically do not receive good valuations and we think the market is unlikely to discern between mark-to-market from technical dislocation versus NAV decreases from credit issues and cash flow impairment and thus we think shares will decline with NAV despite the underlying economics of the assets improving during this time.
In 2019, we think NAV/share will decline to $5.95 from our estimate of $7.47 in 4Q18 but we expect NIM to jump to 12.16% from 11.16% Y/Y. We do not expect much of a benefit in 4Q18 from recent equity market volatility as credit spreads remain stubbornly low. We remind readers that equities would need to be much more volatile for a prolonged period of time before credit is impacted to the point of improving spreads.
We are maintaining our SELL rating and $5 price target. Our $5 price target represents a 16% discount to our 4Q19 NAV/share estimate. We think is reasonable as the market will likely discount shares meaningfully if the volatility we anticipate in loan markets materializes. " (11/5/2018)
Has Oxford Square Capital been receiving favorable news coverage?
Media stories about OXSQ stock have trended positive this week, according to InfoTrie Sentiment. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Oxford Square Capital earned a media sentiment score of 2.3 on InfoTrie's scale. They also gave headlines about the company a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the stock's share price in the near future.
Who are some of Oxford Square Capital's key competitors?
Some companies that are related to Oxford Square Capital include Hercules Capital (HTGC), Liberty All-Star Equity Fund (USA), Boulder Growth & Income Fund (BIF), PIMCO High Income Fund (PHK), Apollo Investment (AINV), AllianceBernstein Global Hgh Incm Fd (AWF), Tekla Healthcare Investors (HQH), Solar Capital (SLRC), Templeton Global Income Fund (GIM), Blackrock Muniyield Insured Fund (MYI), General American Investors (GAM), Goldman Sachs BDC (GSBD), Invesco Van Kampen Munpl Oprtnty Tr (VMO), Invesco Van Kmpn Trst Fr Invst Grd Mncpl (VGM) and Invesco Municipal Trust (VKQ).
Who are Oxford Square Capital's key executives?
Oxford Square Capital's management team includes the folowing people:
- Jonathan H. Cohen, Chief Executive Officer & Director
- Saul B. Rosenthal, President & Chief Operating Officer
- Bruce L. Rubin, CFO, Secretary, Treasurer & CAO
- Gerald R. Cummins, Chief Compliance Officer
Who are Oxford Square Capital's major shareholders?
Oxford Square Capital's stock is owned by many different of institutional and retail investors. Top institutional investors include Advisors Asset Management Inc. (1.01%), Selz Capital LLC (0.99%), Van ECK Associates Corp (0.81%), Two Sigma Advisers LP (0.62%), Legal & General Group Plc (0.44%) and BlackRock Inc. (0.44%). Company insiders that own Oxford Square Capital stock include George Stelljes III, Jonathan H Cohen, Saul B Rosenthal and Steven P Novak. View Institutional Ownership Trends for Oxford Square Capital.
Which institutional investors are selling Oxford Square Capital stock?
OXSQ stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Two Sigma Investments LP, Selz Capital LLC, D. E. Shaw & Co. Inc., Advisors Asset Management Inc., Two Sigma Advisers LP, Macquarie Group Ltd. and Van ECK Associates Corp. View Insider Buying and Selling for Oxford Square Capital.
Which institutional investors are buying Oxford Square Capital stock?
OXSQ stock was purchased by a variety of institutional investors in the last quarter, including Geode Capital Management LLC, Koshinski Asset Management Inc., Legal & General Group Plc, Wedbush Securities Inc., Quantamental Technologies LLC, Stephens Inc. AR, First Foundation Advisors and Great West Life Assurance Co. Can. Company insiders that have bought Oxford Square Capital stock in the last two years include George Stelljes III, Jonathan H Cohen, Saul B Rosenthal and Steven P Novak. View Insider Buying and Selling for Oxford Square Capital.
How do I buy shares of Oxford Square Capital?
Shares of OXSQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Oxford Square Capital's stock price today?
One share of OXSQ stock can currently be purchased for approximately $6.70.
How big of a company is Oxford Square Capital?
Oxford Square Capital has a market capitalization of $324.95 million and generates $61.42 million in revenue each year. The company earns $43.60 million in net income (profit) each year or $0.60 on an earnings per share basis.
What is Oxford Square Capital's official website?
How can I contact Oxford Square Capital?
Oxford Square Capital's mailing address is 8 SOUND SHORE DRIVE SUITE 255, GREENWICH CT, 06830. The company can be reached via phone at 203-983-5275 or via email at [email protected]ecapital.com.
MarketBeat Community Rating for Oxford Square Capital (NASDAQ OXSQ)
MarketBeat's community ratings are surveys of what our community members think about Oxford Square Capital and other stocks. Vote "Outperform" if you believe OXSQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OXSQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
